Nursing Home News — Page 58

The resident, identified in inspection records only as R7, received two types of insulin: Humalog, a fast-acting insulin, and Glargine, a long-acting insulin.

The citation, issued August 13 under a federal category covering quality of life and care, is the kind that rarely makes headlines.

Not the family members or legal representatives responsible for making decisions on their behalf.

The deficiency was rated at Scope/Severity Level D, meaning inspectors found it to be an isolated incident with no documented actual harm.

A complaint inspection at Bellevue Post Acute, a skilled nursing facility at 2424 156th Avenue Northeast, concluded on August 12, 2025.

The deficiency, one of 13 cited during the inspection, fell under the category of nutrition and dietary care.

The citation, issued August 13, 2025, came during a complaint inspection.

The citation, issued under a regulatory category covering resident assessment and care planning, was classified as a pattern-level deficiency.

Inspectors classified it as an isolated incident with no documented actual harm, but with potential for more than minimal harm to residents.

The deficiency was not an isolated slip.

Federal health inspectors visited the facility on August 13, 2025, responding to a complaint.

Federal health inspectors cited the facility on August 13, 2025, for failing to create and implement admission care plans within that 48-hour period.